1028.80
0.27%
BOB Capital Markets Ltd.
Strong Q1 with EBITDA/PAT beat of 10%/6% despite slight miss on revenue
Alivus Life Sciences.. has an average target of 1152.00 from 2 brokers.
More from Alivus Life Sciences Ltd.
Recommended